Introduction
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and results in significant morbidity and mortality. The Cox‐Maze IV procedure (CMP‐IV) has been shown to have excellent efficacy in returning patients to sinus rhythm, but there have been few reports of late follow‐up in sizable cohorts of patients with longstanding persistent AF, the most difficult type of AF to treat.
Methods and Results
Between May 2003 and March 2020, 174 consecutive patients underwent a stand‐alone CMP‐IV for longstanding persistent AF. Rhythm outcome was assessed postoperatively for up to 10 years, primarily via prolonged monitoring (Holter monitor, pacemaker interrogation, or implantable loop recorder). Fine‐Gray regression was used to investigate factors associated with atrial tachyarrhythmia (ATA) recurrence, with death as a competing risk. Median duration of preoperative AF was 7.8 years (interquartile range: 4.0–12.0 years), with 71% (124/174) having failed at least one prior catheter‐based ablation. There were no 30‐day mortalities. Freedom from ATAs was 94% (120/128), 83% (53/64), and 88% (35/40) at 1, 5, and 7 years, respectively. On regression analysis, preoperative AF duration and early postoperative ATAs were associated with late ATAs recurrence.
Conclusion
Despite the majority of patients having a long‐duration of preoperative AF and having failed at least one catheter‐based ablation, the stand‐alone CMP‐IV had excellent late efficacy in patients with longstanding persistent AF, with low morbidity and no mortality. We recommend consideration of stand‐alone CMP‐IV for patients with longstanding persistent AF who have failed or are poor candidates for catheter ablation.
Introduction: Atrial fibrillation (AF) is the most common sustained
cardiac arrhythmia, and results in significant morbidity and mortality.
The Cox-Maze IV procedure (CMP-IV) has been shown to have excellent
efficacy in returning patients to sinus rhythm, but there have been few
reports of late follow-up in sizable cohorts of patients with
longstanding persistent AF, the most difficult type of AF to treat.
Methods & Results: Between May 2003 and March 2020, 174 consecutive
patients underwent a stand-alone CMP-IV for longstanding persistent AF.
Rhythm outcome was assessed postoperatively for up to 10 years,
primarily via prolonged monitoring (Holter monitor, pacemaker
interrogation, or implantable loop recorder). Fine-Gray regression was
used to investigate factors associated with atrial tachyarrhythmia (ATA)
recurrence, with death as a competing risk. Median duration of
preoperative AF was 7.8 years (interquartile range [IQR] 4.0-12.0
years), with 71% (124/174) having failed at least one prior
catheter-based ablation. There were no 30-day mortalities. Freedom from
ATAs was 94% (120/128), 83% (53/64), and 88% (35/40) at 1, 5, and 7
years, respectively. On regression analysis, preoperative AF duration
and early postoperative ATAs were associated with late ATAs recurrence.
Conclusion: Despite the majority of patients having a long-duration of
preoperative AF and having failed at least one catheter-based ablation,
the stand-alone CMP-IV had excellent late efficacy in patients with
longstanding persistent AF, with low morbidity and no mortality. We
recommend consideration of stand-alone CMP-IV for patients with
longstanding persistent AF who have failed or are poor candidates for
catheter ablation.
Objective Obesity is a strong and independent factor for the development of atrial fibrillation (AF), and adversely impacts the success of catheter ablation procedures for AF. This study evaluated the impact of body mass index (BMI) on the outcomes following surgical ablation of AF. Methods Between 2003 and 2019, 236 patients underwent a stand-alone biatrial Cox maze IV procedure (CMP-IV) for refractory AF. Obesity was defined as BMI ≥30 kg/m2. Patients were divided into two groups: BMI <30 kg/m2 ( n = 100) and BMI ≥30 kg/m2 ( n = 136). Freedom from atrial tachyarrhythmia (ATA) was determined using electrocardiography, Holter, or pacemaker interrogation at 1 year and annually thereafter. Recurrence was defined as any documented ATA lasting ≥30 s. Predictors of recurrence were determined using multivariable logistic regression. Preoperative and procedural outcomes were compared between groups. Results Obese patients had a higher rate of diabetes (16% vs 7%, P = 0.044) and larger left atrial diameter (4.9 ± 1.1 cm vs 4.6 ± 1.0 cm, P = 0.021) when compared to non-obese patients. There was no difference in major complication rate between the groups (4% vs 7%, P = 0.389). There was no operative mortality in either group. During 4.1 ± 2.4 years of follow-up, there was no significant difference in freedom from ATA with or without antiarrhythmic drugs in obese patients when compared to the non-obese group ( P > 0.05). Absence of sinus rhythm at discharge predicted AF recurrence up to 7 years postoperatively. Conclusions As opposed to catheter ablation, obesity did not adversely impact the short and long-term outcomes of stand-alone surgical ablation with CMP-IV, and BMI was not a predictor of AF recurrence. Additionally, there was no significant increase in major complications in obese patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.